| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pharmacology and Center for Pharmacogenetics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
IL-1
and IL-1
are proinflammatory cytokines that promote activation of intracellular signaling cascades, leading to stabilization of certain mRNAs and activation of transcription factors. IL-1R type I (IL-1RI) binds IL-1 and IL-1, and subsequent recruitment of the membrane-bound IL-1R accessory protein (mIL-1RAcP) facilitates signal transduction. Two alternatively spliced isoforms, soluble IL-1RAcP (sIL-1RAcP) and sIL-1RAcP-, which lack transmembrane and intracellular domains, have been described. The sIL-1RAcP and possibly sIL-1RAcP- can inhibit IL-1 signaling. Proportional expression of the different IL-1RAcP splice variants may be an important determinant of responsiveness to IL-1. We show that although both mIL-1RAcP and sIL-1RAcP mRNAs are widely expressed in human tissue, their relative proportions differ significantly in a tissue-specific manner. Turnover studies revealed that the sIL-1RAcP mRNA has a half-life of 
48 h in both the kidney cell line 293 and the hepatoma cell line HepG2. The mIL-1RAcP mRNA has a similar half-life in 293 cells, but a considerably shorter half-life of 5 h in HepG2 cells. Using luciferase reporter constructs, we demonstrated that this specific destabilization of the mIL-1RAcP mRNA in the latter cell type is mediated by its 2.8-kb 3'-untranslated region. Deletion analysis further established that the cell line-specific instability does not involve AU-rich elements, but is mediated by several novel elements that appear to act independently; such elements may be recognized by proteins expressed specifically in some, but not all, tissues. These data demonstrate that the cellular capacity to respond to IL-1 is tightly regulated in a tissue-specific manner.
This article has been cited by other articles:
|
|
 |
|
  K. K. W. To, Z. Zhan, T. Litman, and S. E. Bates Regulation of ABCG2 Expression at the 3' Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line Mol. Cell. Biol., September 1, 2008; 28(17): 5147 - 5161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-H. Chang, C.-B. Wu, Y.-J. Chen, C.-Y. Weng, W.-P. Wong, Y.-J. Chen, B.-E. Chang, M.-H. Chen, and C.-C.J. Yao MMP-3 Response to Compressive Forces in vitro and in vivo Journal of Dental Research, July 1, 2008; 87(7): 692 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Chackerian, E. R. Oldham, E. E. Murphy, J. Schmitz, S. Pflanz, and R. A. Kastelein IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex J. Immunol., August 15, 2007; 179(4): 2551 - 2555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chowdhury, S. Krishnan, C. G. Tsokos, J. W. Robertson, C. U. Fisher, M. P. Nambiar, and G. C. Tsokos Stability and Translation of TCR {zeta} mRNA Are Regulated by the Adenosine-Uridine-Rich Elements in Splice-Deleted 3' Untranslated Region of {zeta}-Chain J. Immunol., December 1, 2006; 177(11): 8248 - 8257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Chowdhury, C. G. Tsokos, S. Krishnan, J. Robertson, C. U. Fisher, R. G. Warke, V. G. Warke, M. P. Nambiar, and G. C. Tsokos Decreased Stability and Translation of T Cell Receptor {zeta} mRNA with an Alternatively Spliced 3'-Untranslated Region Contribute to {zeta} Chain Down-regulation in Patients with Systemic Lupus Erythematosus J. Biol. Chem., May 13, 2005; 280(19): 18959 - 18966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Okazaki, K. Imai, R. F. Kikuno, K. Misawa, M. Kawai, S. Inamoto, R. Ohara, T. Nagase, O. Ohara, and H. Koga Influence of the 3'-UTR-length of mKIAA cDNAs and their Sequence Features to the mRNA Expression Level in the Brain DNA Res, January 1, 2005; 12(3): 181 - 189. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
